FDA Clearance Tracker · P080006-S073
ATTAIN PERFORMA MODEL 4398 AND 4598 LEFT VENTRICULAR LEADS
Last checked: Nov 20, 2026Latest source record: Dec 10, 2014 (this decision)Source: openFDAMethods & limitations
Decided
Dec 10, 2014
Approved
Time to decision
92 days
Received Sep 9, 2014. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P080006-S073
- Device name
- ATTAIN PERFORMA MODEL 4398 AND 4598 LEFT VENTRICULAR LEADS
- Applicant
- Medtronic, Inc.
- Applicant location
- Minneapolis, MN
- Received
- Sep 9, 2014
- Decided
- Dec 10, 2014
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P080006
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE ATTAIN PERFORMATM LEFT VENTRICULAR LEADS (MODELS 4398 AND 4598), INDICATED FOR CHRONIC PACING IN THE LEFT VENTRICLE VIA THE CARDIAC VEIN, WHEN USED WITH A COMPATIBLE MEDTRONIC CARDIAC RESYNCHRONIZATION THERAPY (CRT) SYSTEM.
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.